International Clinical Trial: Study of the effect of non-adherence to standard asthma preventer treatment (inhaled steroids) on response to biologic treatment (mepolizumab) in people with severe asthma

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ISRCTN10555748) titled 'Study of the effect of non-adherence to standard asthma preventer treatment (inhaled steroids) on response to biologic treatment (mepolizumab) in people with severe asthma' on Sept. 2.

Study Type: Observational

Study Design: Cohort study

Primary Sponsor: University Hospitals Birmingham NHS Foundation Trust

Condition: Severe eosinophilic asthma Respiratory

Intervention: Adult severe eosinophilic asthma patients of the University Hospitals Birmingham NHS Foundation Trust under the care of the Birmingham Regional Severe Asthma Service (BRSAS) based at Heartlands Hospital. The BRSAS network covers the West Mid...